Ten Bay Bio key facts
- Provider of biological therapies intended to address complex diseases in immunology.
- It has raised $11.6M across 1 recorded rounds; the latest was Early Stage VC ($11.5M) in Jul 2024.
- Notable investors include Wisconsin Investment Management Company, Santé Ventures, Venture Investors Health Fund.
- Ten Bay Bio has filed 2 Form Ds with the SEC since 2024, most recently May 2025 ($11.5M sold to 6 investors).
- Status: Privately Held (backing).
Who backs Ten Bay Bio
3- ·Watch Ten Bay Bio: the Monday email on marks, rounds and moves
Ten Bay Bio funding rounds
1 roundsHow much has Ten Bay Bio raised?
Ten Bay Bio has raised $11.6 million across 1 recorded round since 2024. The largest was an $11.5 million early-stage round in Jul 2024.
Ten Bay Bio has filed 2 Form Ds with the SEC since 2024, most recently in May 2025 ($11.5 million sold to 6 investors).
Ten Bay Bio investors
3 investors are on record for Ten Bay Bio, including Wisconsin Investment Management Company, Santé Ventures and Venture Investors Health Fund. The early-stage round in Jul 2024 drew 6 investors.
Who runs Ten Bay Bio
5 people are listed on the Ten Bay Bio team: 5 board members. 5 of them have a verified direct contact on file.
About Ten Bay Bio
Provider of biological therapies intended to address complex diseases in immunology. The company is currently operating in stealth mode.
- Sector
- Healthcare
- HQ
- Milwaukee, WI, United States
- Founded
- 2024
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Ten Bay Bio doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.